.jpg)
An intricate exploration of Levocarnitine Chloride, a small molecule drug, known for its therapeutic applications in the realm of nervous system, cardiovascular, skin, and musculoskeletal diseases.
Table of Contents
Introduction
Levocarnitine Chloride, classified under small molecule drugs, is a powerful medicinal compound recognized for its significant influence in various therapeutic areas1. It has the molecular formula C7H16ClNO3 and is identified under the CAS Registry number 6645-46-1.
Synonyms
Also known as Levocarnitine chloride (JAN) or L-cartin, this compound exhibits a variety of therapeutic properties, making it a valuable asset in the pharmaceutical sector1.
Target and Mechanism
The intricate details of Levocarnitine Chloride's target and mechanism of action are yet to be fully understood. Further research is required in this field for a more comprehensive understanding.
Therapeutic Areas
Levocarnitine Chloride finds its applicability in a multitude of therapeutic areas. It is predominantly used in the treatment of disorders related to the nervous system, cardiovascular diseases, and ailments pertaining to skin and musculoskeletal systems1.
Active Indication
The primary active indication for Levocarnitine Chloride is in the treatment of Systemic Carnitine Deficiency. This condition is characterized by low levels of carnitine in the body, which can lead to various health complications.
Originator Organization
The details of the originator organization for Levocarnitine Chloride remain undisclosed. The active organization involved in its development is also not available at the moment.
Regulation
The regulatory aspects of Levocarnitine Chloride are complex and vary across different countries. The drug has received global approval for its use in treating Systemic Carnitine Deficiency1.
Structure
Levocarnitine Chloride's structure can be identified by the InChIKey JXXCENBLGFBQJM-FYZOBXCZSA-N. Its structure comprises of a combination of carbon, hydrogen, chlorine, nitrogen, and oxygen atoms which give it its unique therapeutic properties.
Clinical Trial Analysis
Detailed analysis of the clinical trials for Levocarnitine Chloride can provide valuable insights into its efficacy, side-effects, and overall performance. Researchers and scientists can use these findings to further their understanding of this compound and its potential applications1.
Approval
Levocarnitine Chloride has received global approval for its therapeutic applications. It is used worldwide in the treatment of Systemic Carnitine Deficiency1.
Footnotes
Reference Article 1: OverviewBasic InfoDrug TypeSmall molecule drugSynonymsLevocarnitine chloride (JAN), L-cartinTarget-Mechanism-Therapeutic AreasNervous System Diseases, Cardiovascular Diseases, Skin and Musculoskeletal Diseases+ [1]Active IndicationSystemic Carnitine DeficiencyInactive Indication-Originator Organization-Active Organization-Inactive Organization-Highest Phase (Global)ApprovedFirst Approval Date(Global)-Regulation-StructureMolecular FormulaC7H16ClNO3InChIKeyJXXCENBLGFBQJM-FYZOBXCZSA-NCAS Registry6645-46-1External LinkR&D StatusIndicationHighest PhaseCountry/LocationOrganizationSystemic Carnitine DeficiencyApproved--Core PatentBoost your research with our Core Patent data.Clinical Trial AnalysisIdentify the latest clinical trials across global registries.ApprovalAccelerate your research with the latest regulatory approval information.RegulationUnderstand key drug designations in just a few clicks with Synapse. ↩ ↩2 ↩3 ↩4 ↩5 ↩6
Comentários